ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 120 filers reported holding ANTARES PHARMA INC in Q4 2018. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $336,000 | +30.2% | 100,000 | 0.0% | 0.02% | +28.6% |
| Q2 2018 | $258,000 | +17.3% | 100,000 | 0.0% | 0.01% | +16.7% |
| Q1 2018 | $220,000 | +10.6% | 100,000 | 0.0% | 0.01% | +9.1% |
| Q4 2017 | $199,000 | -38.6% | 100,000 | 0.0% | 0.01% | -38.9% |
| Q3 2017 | $324,000 | +1.9% | 100,000 | 0.0% | 0.02% | -21.7% |
| Q2 2017 | $318,000 | -36.3% | 100,000 | -16.7% | 0.02% | -65.7% |
| Q2 2013 | $499,000 | – | 120,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,820,524 | $4,697,000 | 3.00% |
| ARMISTICE CAPITAL, LLC | 12,050,000 | $31,089,000 | 2.03% |
| Broadfin Capital, LLC | 4,623,247 | $11,928,000 | 1.88% |
| Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
| Healthcare Value Capital, LLC | 100,000 | $258,000 | 0.73% |
| MYCIO WEALTH PARTNERS, LLC | 2,433,500 | $6,278,000 | 0.65% |
| PERKINS CAPITAL MANAGEMENT INC | 317,500 | $819,000 | 0.59% |
| Brown Advisory Securities, LLC | 275,000 | $710,000 | 0.12% |
| FALCON POINT CAPITAL, LLC | 222,501 | $574,000 | 0.11% |
| Avenir Corp | 291,597 | $752,000 | 0.09% |